We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.6B
AUM Growth
-$234M
Cap. Flow
-$434M
Cap. Flow %
-4.08%
Top 10 Hldgs %
11.4%
Holding
561
New
183
Increased
121
Reduced
99
Closed
141

Top Buys

Rank Stock Value
1
WFM
Whole Foods Market Inc
WFM
+$119M
2
BAX icon
Baxter International
BAX
+$107M
3
ABT icon
Abbott
ABT
+$103M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$103M
5
KHC icon
Kraft Heinz
KHC
+$92.4M

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$176M
2
CSCO icon
Cisco
CSCO
+$151M
3
CELG
Celgene Corp
CELG
+$148M
4
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$145M
5
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$135M

Sector Composition

Rank Sector Weight
1 Healthcare 17.9%
2 Technology 14.54%
3 Industrials 10.72%
4 Consumer Discretionary 10.71%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WRB icon
401
W.R. Berkley
WRB
$26.6B
$539K 0.01%
+30,375
New +$505K
CNO icon
402
CNO Financial Group
CNO
$5.1B
$524K ﹤0.01%
+30,000
New +$564K
BLRX
403
BioLineRX
BLRX
$11.8M
$490K ﹤0.01%
1,020
+21
+2% +$11.8K
SYRE icon
404
Spyre Therapeutics
SYRE
$9.25B
$486K ﹤0.01%
+4,000
New +$767K
IBP icon
405
Installed Building Products
IBP
$6.49B
$445K ﹤0.01%
+12,269
New +$381K
MB
406
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
$404K ﹤0.01%
+25,000
New +$350K
WIBC
407
DELISTED
WILSHIRE BANCORP INC
WIBC
$394K ﹤0.01%
+37,812
New +$407K
BIOA
408
CALL
DELISTED
BioAmber Inc.
BIOA
$390K ﹤0.01%
131,009
+2,658
+2% +$9.7K
RLJE
409
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$390K ﹤0.01%
200,000
+133,333
+200% +$245K
NTBL
410
CALL
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$384K ﹤0.01%
2,381
– –
WINT
411
CALL
DELISTED
Windtree Therapeutics Inc
WINT
$345K ﹤0.01%
178,570
– –
ALPN
412
DELISTED
Alpine Immune Sciences Inc
ALPN
$310K ﹤0.01%
16,852
+342
+2% +$6.07K
CTIC
413
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$268K ﹤0.01%
78,949
+1,602
+2% +$7.35K
BLPH
414
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$260K ﹤0.01%
9,798
+199
+2% +$5.46K
NVCN
415
DELISTED
Neovasc Inc.
NVCN
$252K ﹤0.01%
20
+1
+5% +$49.4K
PARN
416
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$240K ﹤0.01%
147,458
– –
KALV
417
DELISTED
KalVista Pharmaceuticals
KALV
$103K ﹤0.01%
11,059
+224
+2% +$2.59K
GEVO icon
418
CALL
Gevo
GEVO
$382M
$57K ﹤0.01%
243
– –
TTHI
419
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$56K ﹤0.01%
38,285
-254,067
-87% -$220K
BIND
420
CALL
DELISTED
BIND THERAPEUTICS INC
BIND
$45K ﹤0.01%
114,786
– –
AER icon
421
AerCap
AER
$23.8B
– –
-887,963
Closed -$34.4M
ALLT icon
422
Allot
ALLT
$383M
– –
-1,017,207
Closed -$5.32M
ANF icon
423
Abercrombie & Fitch
ANF
$5B
– –
-677,234
Closed -$21.4M
ARCC icon
424
Ares Capital
ARCC
$14.4B
– –
-156,131
Closed -$2.32M
BAC icon
425
Bank of America
BAC
$442B
– –
-3,346,253
Closed -$45.2M
15 16
17
18 19

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q2 2016 Portfolio in Review

As of Q2 2016, Alyeska Investment Group held 561 positions worth $10.6B, down 2.2% from $10.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group withdrew a net $434M in Q2 2016, closing 141 positions and reducing 99 holdings. Its most notable exit was Cisco, an estimated $151M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Baxter International worth $111M.

  • Alyeska Investment Group's largest Q2 2016 buy was Baxter International: 2,450,018 shares worth $111M.
  • Alyeska Investment Group added most to Whole Foods Market Inc in Q2 2016, an estimated $119M increase.
  • Alyeska Investment Group's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $176M.
  • Alyeska Investment Group fully exited Cisco in Q2 2016, selling an estimated $151M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $10.6B portfolio in Q2 2016.
  • Alyeska Investment Group opened 183 new positions and closed 141 in Q2 2016.
  • Alyeska Investment Group's portfolio value fell 2.2% quarter-over-quarter to $10.6B.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.